Haibo Wang

Corporate Officer/Principal en HARPOON THERAPEUTICS, INC. .

Consumer Services

Health Technology

Commercial Services

Perfil

Haibo Wang is a professional who currently holds the position of Senior Vice President-Business Development at Harpoon Therapeutics, Inc. He previously worked as Vice President-Business Development at Hummingbird Bioscience Pte Ltd.
Wang holds an MBA from Duke University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Tsinghua University.

Cargos activos de Haibo Wang

Empresas	Cargo	Inicio
HARPOON THERAPEUTICS, INC.	Corporate Officer/Principal	01/08/2023

Todos los cargos activos de Haibo Wang

Antiguos cargos conocidos de Haibo Wang.

Empresas	Cargo	Fin
Hummingbird Bioscience Pte Ltd. Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Haibo Wang.

Formación de Haibo Wang.

Duke University	Masters Business Admin
The Johns Hopkins University	Graduate Degree
Tsinghua University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Haibo Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
HARPOON THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Hummingbird Bioscience Pte Ltd. Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore.	Commercial Services